BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30874347)

  • 1. Molecular pathogenesis of germinal center-derived B cell lymphomas.
    Pasqualucci L
    Immunol Rev; 2019 Mar; 288(1):240-261. PubMed ID: 30874347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The germinal center in the pathogenesis of B cell lymphomas.
    Pasqualucci L
    Hematol Oncol; 2023 Jun; 41 Suppl 1():62-69. PubMed ID: 37294970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
    Seifert M; Küppers R
    Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models.
    Mossadegh-Keller N; Brisou G; Beyou A; Nadel B; Roulland S
    Front Immunol; 2021; 12():683597. PubMed ID: 34335584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germinal center-derived lymphomas: The darkest side of humoral immunity.
    Mlynarczyk C; Fontán L; Melnick A
    Immunol Rev; 2019 Mar; 288(1):214-239. PubMed ID: 30874354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germinal centres and B cell lymphomagenesis.
    Basso K; Dalla-Favera R
    Nat Rev Immunol; 2015 Mar; 15(3):172-84. PubMed ID: 25712152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human germinal center transcriptional programs are de-synchronized in B cell lymphoma.
    Milpied P; Cervera-Marzal I; Mollichella ML; Tesson B; Brisou G; Traverse-Glehen A; Salles G; Spinelli L; Nadel B
    Nat Immunol; 2018 Sep; 19(9):1013-1024. PubMed ID: 30104629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of apoptosis regulators in germinal centers and germinal center-derived B-cell lymphomas: insight into B-cell lymphomagenesis.
    Kondo E; Yoshino T
    Pathol Int; 2007 Jul; 57(7):391-7. PubMed ID: 17587238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epigenetic view of B-cell disorders.
    Alberghini F; Petrocelli V; Rahmat M; Casola S
    Immunol Cell Biol; 2015 Mar; 93(3):253-60. PubMed ID: 25601271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new frontier of epigenetic heterogeneity in B-cell neoplasms.
    Dominguez PM; Teater M; Shaknovich R
    Curr Opin Hematol; 2017 Jul; 24(4):402-408. PubMed ID: 28375986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.
    Walsh SH; Rosenquist R
    Med Oncol; 2005; 22(4):327-41. PubMed ID: 16260850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
    Béguelin W; Teater M; Meydan C; Hoehn KB; Phillip JM; Soshnev AA; Venturutti L; Rivas MA; Calvo-Fernández MT; Gutierrez J; Camarillo JM; Takata K; Tarte K; Kelleher NL; Steidl C; Mason CE; Elemento O; Allis CD; Kleinstein SH; Melnick AM
    Cancer Cell; 2020 May; 37(5):655-673.e11. PubMed ID: 32396861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma.
    Koues OI; Kowalewski RA; Chang LW; Pyfrom SC; Schmidt JA; Luo H; Sandoval LE; Hughes TB; Bednarski JJ; Cashen AF; Payton JE; Oltz EM
    Immunity; 2015 Jan; 42(1):186-98. PubMed ID: 25607463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Models of Germinal Center Derived B-Cell Lymphomas.
    Meyer SN; Koul S; Pasqualucci L
    Front Immunol; 2021; 12():710711. PubMed ID: 34456919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The many layers of epigenetic dysfunction in B-cell lymphomas.
    Jiang Y; Dominguez PM; Melnick AM
    Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of BCL6 during germinal center B cell development.
    Huang C; Melnick A
    Sci China Life Sci; 2015 Dec; 58(12):1226-32. PubMed ID: 26566802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUM1: a step ahead toward the understanding of lymphoma histogenesis.
    Gaidano G; Carbone A
    Leukemia; 2000 Apr; 14(4):563-6. PubMed ID: 10764139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells.
    Pan Z; Shen Y; Du C; Zhou G; Rosenwald A; Staudt LM; Greiner TC; McKeithan TW; Chan WC
    Am J Pathol; 2003 Jul; 163(1):135-44. PubMed ID: 12819018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.